Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has reported Total Non-Current Liabilities for 6 consecutive years, with $84.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 43.75% year-over-year to $84.9 million; the TTM figure through Dec 2025 stood at $84.9 million (up 43.75% YoY), while the FY2025 annual figure was $84.9 million, up 43.75% from the prior year.
• Total Non-Current Liabilities came in at $84.9 million for Q4 2025 at Cellebrite DI, up from $69.7 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $359.5 million in Q2 2024, with the low at $41.4 million in Q3 2021.
• Average Total Non-Current Liabilities over 5 years is $149.8 million, with a median of $124.8 million recorded in 2022.
• Across the five-year window, Total Non-Current Liabilities jumped 466.45% in 2021 and sank 81.76% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $226.6 million in 2021, then sank by 46.3% to $121.7 million in 2022, then jumped by 101.27% to $244.8 million in 2023, then sank by 75.89% to $59.0 million in 2024, then soared by 43.75% to $84.9 million in 2025.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $84.9 million, $69.7 million, and $69.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.